Safety and tolerability of a 5 mg starting dose of vericiguat among patients with heart failure: The VELOCITY study.

ABSTRACT:

SUBMITTER: Greene SJ 

PROVIDER: S-EPMC12803652 | biostudies-literature | 2025 Dec

REPOSITORIES: biostudies-literature